FDA_RFQ_1179559_U_Q&A.pdf

PDF 64 KB Posted

Attached to
Nutrient Cell Analyzer
Solicitation number
FDA-RFQ-1179559-U
Issued by

About this file

Q&A

View the file

Other files

File Type Posted
FDA_RFQ_1179559_U.doc DOC document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

FDA-RFQ-1179559-U Q&A

Nutrient Cell Analyzer

Document Type: Amendment 1: Questions & Answers Solicitation Number: FDA-RFQ-1179559-U Posted Date: 5 July 2017 Response Date: 12 July 2017 REMAINS THE SAME NAICS Code: 334516, Analytical Laboratory Instrument

Manufacturing, Small Size Standard 1,000 Employees.

Part 1 – Question

Question:

I am working on putting this quote together and have a question about consumables (Page 1) & (Page 4) discussed in the RFQ.

1. Page 1 requirement: The quantity and therefore the dollar value of the consumables needed would vary depending on the usage of equipment during this time frame. As a solution I could quote based strictly on expiration dates of the consumables. As an example if a consumable, once installed into the system would normally be usable for 21 days then; 180days / 21days = 8.57 – I would quote 9 of these items. Is this acceptable?

2. Page 4 requirement: “Consumables minimums” - Do you want to prepay this minimum quantity for the # of years you opt for a service contract?

Part 2 – Answer

Answer: I think your approach for item 1 and 2 should work.

#2, If the program decides to exercise the option, it would be a modification to the base contract and invoiced at the time of the modification.

RESPONSE DATES

Questions Due Date: All questions shall be submitted via email to Christine Russman at Christine.Russman@fda.hhs.gov before 3:30 pm 7 July 2017.

RFQ Due Date: All quotes and revisions shall be submitted via email to Christine Russman at Christine.Russman@fda.hhs.gov before 3:30 PM Eastern Time on 12 July 2017.

All other terms and conditions of this Combined Synopsis/Solicitation remain unchanged.

1 | P a g e mailto:Christine.Russman@fda.hhs.gov

File details come from the government source that posted it. Updated .